Skip to main content

Bromfenac News

Related terms: Bromfenac Ophthalmic

FDA Medwatch Alert: Drug Safety Communication: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) - Avoid Use of NSAIDs in Pregnancy at 20 Weeks or Later

ISSUE: FDA is warning that use of NSAIDs around 20 weeks or later in pregnancy may cause rare but serious kidney problems in an unborn baby. This can lead to low levels of amniotic fluid surrounding...

Sun Pharma Receives FDA Approval For BromSite (bromfenac ophthalmic solution)

Mumbai, April 09, 2016: Sun Pharma (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE:524715, Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) today...

Bausch + Lomb Receives FDA Approval for Prolensa

MADISON, NJ - Bausch + Lomb, the global eye health company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (NDA) for Prolensa...

ISTA Pharmaceuticals Receives FDA Approval for Bromday

IRVINE, Calif., Oct. 16 /PRNewswire-FirstCall/ – ISTA Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved the Company's supplemental New Drug Application...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Bromfenac patient information at Drugs.com